Analyst Recommendations

Citigroup analyst issues BUY recommendation for NUE on March 13, 2024 04:35AM ET. NUE was trading at $182.89 at issue of the analyst recommendation.The overall analyst consensus :...

March 13, 2024   NUE 0.75%

Barclays analyst issues UNDERWEIGHT recommendation for ADM on March 11, 2024 04:56AM ET. The previous analyst recommendation was Overweight.ADM was trading at $54.81 at issue of the analyst...

March 11, 2024   ADM 0.52%

BMO Capital analyst issues MARKET PERFORM recommendation for ADM on March 11, 2024 04:56AM ET. The previous analyst recommendation was Market Perform.ADM was trading at $54.81 at issue...

March 11, 2024   ADM 0.52%

Barclays analyst issues UNDERWEIGHT recommendation for ADM on March 11, 2024 04:56AM ET. The previous analyst recommendation was Overweight.ADM was trading at $54.81 at issue of the analyst...

March 11, 2024   ADM 0.52%

Goldman Sachs analyst issues NEUTRAL recommendation for ADM on March 11, 2024 04:56AM ET. The previous analyst recommendation was Neutral.ADM was trading at $54.81 at issue of the...

March 11, 2024   ADM 0.52%

Goldman Sachs analyst issues NEUTRAL recommendation for ADM on March 11, 2024 04:56AM ET. The previous analyst recommendation was Neutral.ADM was trading at $54.81 at issue of the...

March 11, 2024   ADM 0.52%

Barclays analyst issues UNDERWEIGHT recommendation for ADM on March 11, 2024 04:56AM ET. The previous analyst recommendation was Overweight.ADM was trading at $54.81 at issue of the analyst...

March 11, 2024   ADM 0.52%

BMO Capital analyst issues MARKET PERFORM recommendation for ADM on March 11, 2024 04:56AM ET. The previous analyst recommendation was Market Perform.ADM was trading at $54.81 at issue...

March 11, 2024   ADM 0.52%

Morgan Stanley analyst issues EQUAL-WEIGHT recommendation for MO on March 8, 2024 07:39AM ET. The previous analyst recommendation was Equal-Weight.MO was trading at $41.55 at issue of the...

March 8, 2024   MO 0.01%

Canaccord Genuity analyst issues BUY recommendation for EMR on March 6, 2024 08:00AM ET. The previous analyst recommendation was Buy.EMR was trading at $109.02 at issue of the...

March 6, 2024   EMR 1.89%